127 related articles for article (PubMed ID: 23278975)
1. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
[TBL] [Abstract][Full Text] [Related]
2. Early Stages of Obesity-related Heart Failure Are Associated with Natriuretic Peptide Deficiency and an Overall Lack of Neurohormonal Activation: The Copenhagen Heart Failure Risk Study.
Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Kamstrup PR; Faber J; Køber L; Schou M
Glob Heart; 2020 Mar; 15(1):25. PubMed ID: 32489798
[TBL] [Abstract][Full Text] [Related]
3. Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction.
Cui K; Huang W; Fan J; Lei H
Medicine (Baltimore); 2018 Sep; 97(36):e12277. PubMed ID: 30200170
[TBL] [Abstract][Full Text] [Related]
4. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
Tan ESJ; Chan SP; Liew OW; Chong JPC; Gerard Leong KT; Daniel Yeo PS; Ong HY; Jaufeerally F; Sim D; Ling LH; Lam CSP; Richards AM
JACC Heart Fail; 2024 Mar; 12(3):461-474. PubMed ID: 37897459
[TBL] [Abstract][Full Text] [Related]
5. Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.
Truong QA; Siegel E; Karakas M; Januzzi JL; Bamberg F; Mahabadi AA; Dasdemir S; Brady TJ; Bergmann A; Kunde J; Nagurney JT; Hoffmann U; Koenig W
Clin Chem; 2010 Apr; 56(4):651-60. PubMed ID: 20185624
[TBL] [Abstract][Full Text] [Related]
6. Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure.
Spoto S; Argemi J; Di Costanzo R; Gavira Gomez JJ; Salterain Gonzales N; Basili S; Cangemi R; Abbate A; Locorriere L; Masini F; Testorio G; Calarco R; Battifoglia G; Mangiacapra F; Fogolari M; Costantino S; Angeletti S
J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511766
[TBL] [Abstract][Full Text] [Related]
7. Role of NT-proBNP and lung ultrasound in diagnosing and classifying heart failure in a hospitalized oldest-old population: a cross-sectional study.
Landolfo M; Spannella F; Giulietti F; Di Pentima C; Giordano P; Borioni E; Landi L; Di Rosa M; Galeazzi R; Sarzani R
BMC Geriatr; 2024 Apr; 24(1):354. PubMed ID: 38643091
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the circulating N-terminal pro B-type natriuretic peptide and the risk of carotid artery plaque in different glucose metabolic states in patients with coronary heart disease: a CSCD-TCM
Yang T; Zheng H; Pan G; Guo R; Liu F; Liu S; Tao S; Li L; Yang R; Yu C
Cardiovasc Diabetol; 2023 Nov; 22(1):299. PubMed ID: 37919791
[TBL] [Abstract][Full Text] [Related]
9. Comparative accuracy of NT-proBNP and MR-proANP for the diagnosis of acute heart failure in dyspnoeic patients.
Darche FF; Baumgärtner C; Biener M; Müller-Hennessen M; Vafaie M; Koch V; Stoyanov K; Rivinius R; Katus HA; Giannitsis E
ESC Heart Fail; 2017 Aug; 4(3):232-240. PubMed ID: 28772028
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic yield of a heart failure referral pathway using N-terminal pro-brain natriuretic peptide.
Zegard A; Naneishvili T; Viyapurapu R; Desai P; White S; Patel PA; Stegemann B; Zaphiriou A; Qiu T; Leyva F
Open Heart; 2023 Oct; 10(2):. PubMed ID: 37793674
[TBL] [Abstract][Full Text] [Related]
11. Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients.
Rasche FM; Stoebe S; Ebert T; Feige S; Hagendorff A; Rasche WG; Barinka F; Busch V; Sack U; Schneider JG; Schiekofer S
BMC Nephrol; 2017 May; 18(1):175. PubMed ID: 28558715
[TBL] [Abstract][Full Text] [Related]
12. Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure.
Nogi K; Yamamoto R; Ueda T; Nogi M; Ishihara S; Nakada Y; Hashimoto Y; Nakagawa H; Nishida T; Seno A; Onoue K; Watanabe M; Takaya N; Masuda I; Saito Y
J Cardiol; 2023 Dec; 82(6):481-489. PubMed ID: 37247659
[TBL] [Abstract][Full Text] [Related]
13. Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study.
Charitakis E; Walfridsson H; Nylander E; Alehagen U
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27956398
[TBL] [Abstract][Full Text] [Related]
14. N-Terminal Pro B-Type Natriuretic Peptide as a Screening Tool for Inpatient Echocardiogram Requirement Among Patients With Suspected Heart Failure: Using NT-proBNP to Reduce Hospital Length of Stay.
Norman S; Moragues J; Zaki NM; Lee A
Heart Lung Circ; 2023 Oct; 32(10):1215-1221. PubMed ID: 37749024
[TBL] [Abstract][Full Text] [Related]
15. Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.
Kriechbaum SD; Scherwitz L; Wiedenroth CB; Rudolph F; Wolter JS; Haas M; Fischer-Rasokat U; Rolf A; Hamm CW; Mayer E; Guth S; Keller T; Konstantinides SV; Lankeit M; Liebetrau C
ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263045
[TBL] [Abstract][Full Text] [Related]
16. NT-proBNP course during MIS-C post-COVID-19: an observational study.
Bichali S; Ouldali N; Godart F; Maboudou P; Houeijeh A; Leteurtre S
Eur J Pediatr; 2024 Apr; 183(4):1667-1674. PubMed ID: 38206397
[TBL] [Abstract][Full Text] [Related]
17. Reference intervals for N-terminal pro-B-type natriuretic peptide in amniotic fluid between 10 and 34 weeks of gestation.
Merz WM; Leufgen C; Fimmers R; Stoffel-Wagner B; Gembruch U
PLoS One; 2014; 9(12):e114416. PubMed ID: 25490554
[TBL] [Abstract][Full Text] [Related]
18. Interplay between natriuretic peptides and left atrial mechanics and the relation to recurrence of atrial fibrillation following catheter ablation.
Olsen FJ; Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH; Biering-Sørensen T
Int J Cardiovasc Imaging; 2023 Oct; 39(10):1889-1895. PubMed ID: 37428246
[TBL] [Abstract][Full Text] [Related]
19. Bioactive adrenomedullin as a marker of congestion and disease progression in patients with a systemic right ventricle.
Ansari Ramandi MM; Hendriks PM; Voors AA; van den Bosch AE; van Melle JP
Int J Cardiol; 2024 Aug; 408():132107. PubMed ID: 38685456
[TBL] [Abstract][Full Text] [Related]
20. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC.
Bayes-Genis A; Docherty KF; Petrie MC; Januzzi JL; Mueller C; Anderson L; Bozkurt B; Butler J; Chioncel O; Cleland JGF; Christodorescu R; Del Prato S; Gustafsson F; Lam CSP; Moura B; Pop-Busui R; Seferovic P; Volterrani M; Vaduganathan M; Metra M; Rosano G
Eur J Heart Fail; 2023 Nov; 25(11):1891-1898. PubMed ID: 37712339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
